https://www.pharmanow.live/latest-news/dr-reddys-gains-brazil-approval-generic-semaglutide-injection-type-2-diabetes 2026-11-07T22:18:27+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Dr. Reddy's Gains Brazil Approval for Generic Semaglutide Injection Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ee3dd0ad-ab32-448d-9566-2f7fcfc930ca.png https://www.pharmanow.live/latest-news/janssen-fda-full-approval-erdafitinib-fgfr3-urothelial-carcinoma 2026-11-07T22:24:25+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Erdafitinib in Urothelial Carcinoma Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ecd44ed8-8895-4ad7-a731-2211a06c14de.png https://www.pharmanow.live/latest-news/xcovery-holdings-fda-approval-ensartinib-alk-positive-metastatic-nsclc 2026-11-07T22:25:51+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Xcovery Holdings Gains FDA Approval for Ensartinib in ALK-Positive Metastatic NSCLC FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/9feb7df0-a0d9-4a0e-bcea-fabf295adc46.png https://www.pharmanow.live/latest-news/checkpoint-therapeutics-fda-approval-cosibelimab-ipdl-cscc 2026-11-07T22:27:34+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Checkpoint Therapeutics Gains FDA Approval for Cosibelimab-ipdl https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/d3a8f2b4-5a66-4218-ac72-f9f02aa83739.png https://www.pharmanow.live/latest-news/janssen-gains-traditional-fda-approval-rybrevant-egfr-exon-20-nsclc 2026-11-07T22:29:10+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains Traditional FDA Approval for Rybrevant in First-Line EGFR NSCLC Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/4a18bae1-29ce-46eb-ad69-39fb35d7728a.png https://www.pharmanow.live/latest-news/fda-investigates-insertional-oncogenesis-zolgensma-aav-gene-therapy 2026-11-07T21:52:59+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Investigates Oncogenesis Cases Linked to Novartis Zolgensma FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/fb7ba439-62a9-4099-a8b0-0ec2fead954b.png https://www.pharmanow.live/latest-news/advanced-accelerator-applications-fda-approval-lutathera-pediatric-gep-nets 2026-11-07T21:59:00+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Approves Lutathera for Pediatric GEP-NETs Aged 12+ FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/aaa3b0c9-52a8-44e5-8d41-d19a683f20d5.png https://www.pharmanow.live/latest-news/ipsen-fda-approval-onivyde-first-line-metastatic-pancreatic-adenocarcinoma 2026-11-07T22:02:35+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Ipsen Gains FDA Approval for Onivyde in First-Line Metastatic Pancreatic Adenocarcinoma FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/4caac3f6-5904-420b-ab13-b65847aadd53.png https://www.pharmanow.live/latest-news/pfizer-fda-approval-besponsa-pediatric-all-inotuzumab-ozogamicin 2026-11-07T22:11:18+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Pfizer Gains FDA Approval for Besponsa in Pediatric Relapsed or Refractory ALL Patients Pfizer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/570e7530-2e19-4225-b969-ea8d4440cea2.png https://www.pharmanow.live/latest-news/genentech-fda-approval-inavolisib-palbociclib-fulvestrant-pik3ca-breast-cancer 2026-11-07T22:14:38+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Approves Genentech's Inavolisib Triplet with Companion Diagnostic FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ce990ff9-a7cd-4dd2-ae1d-2cad40914331.png https://www.pharmanow.live/latest-news/gsk-fda-approval-blenrep-belantamab-mafodotin-relapsed-refractory-multiple-myeloma-dreamm-7 2026-11-07T22:15:53+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 GSK Gains FDA Approval for Blenrep in Relapsed or Refractory Multiple Myeloma GSK https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/e92b3f54-aaf6-45f5-84fb-838d1fd2b58c.png https://www.pharmanow.live/latest-news/janssen-fda-approval-subcutaneous-rybrevant-faspro-nsclc 2026-11-07T22:16:44+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Subcutaneous Rybrevant Faspro Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/e72a80db-09ed-493a-9017-8ed754a9603f.png https://www.pharmanow.live/latest-news/incyte-fda-approval-axatilimab-csfr-chronic-graft-versus-host-disease 2026-11-07T22:04:44+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Incyte Gains FDA Approval for Axatilimab-csfr in cGVHD Incyte https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/01594cb4-d8de-4d42-987e-492977ca5c3c.png https://www.pharmanow.live/latest-news/janssen-fda-approval-inlexzo-intravesical-system-bcg-unresponsive-bladder-cancer 2026-11-07T21:45:54+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Inlexzo Intravesical System in Bladder Cancer Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/cd6dd217-4cf5-4f38-92ab-345edf9f384c.png